- Home
- AAT vs CLDX Comparison
AAT vs CLDX Comparison
Compare AAT & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAT
- CLDX
- Stock Information
- Founded
- AAT 1967
- CLDX N/A
- Country
- AAT United States
- CLDX United States
- Employees
- AAT N/A
- CLDX N/A
- Industry
- AAT Real Estate Investment Trusts
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- AAT Real Estate
- CLDX Health Care
- Exchange
- AAT Nasdaq
- CLDX Nasdaq
- Market Cap
- AAT 1.2B
- CLDX 1.3B
- IPO Year
- AAT 2011
- CLDX 2008
- Fundamental
- Price
- AAT $19.62
- CLDX $20.10
- Analyst Decision
- AAT Hold
- CLDX Buy
- Analyst Count
- AAT 2
- CLDX 9
- Target Price
- AAT $21.00
- CLDX $50.00
- AVG Volume (30 Days)
- AAT 390.2K
- CLDX 664.5K
- Earning Date
- AAT 04-29-2025
- CLDX 05-08-2025
- Dividend Yield
- AAT 6.94%
- CLDX N/A
- EPS Growth
- AAT 49.17
- CLDX N/A
- EPS
- AAT 1.33
- CLDX N/A
- Revenue
- AAT $451,281,000.00
- CLDX $7,559,000.00
- Revenue This Year
- AAT $2.97
- CLDX N/A
- Revenue Next Year
- AAT N/A
- CLDX N/A
- P/E Ratio
- AAT $14.77
- CLDX N/A
- Revenue Growth
- AAT 2.65
- CLDX 24.49
- 52 Week Low
- AAT $16.69
- CLDX $14.40
- 52 Week High
- AAT $29.15
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- AAT 54.09
- CLDX 53.76
- Support Level
- AAT $19.24
- CLDX $18.47
- Resistance Level
- AAT $19.88
- CLDX $20.42
- Average True Range (ATR)
- AAT 0.43
- CLDX 1.29
- MACD
- AAT 0.13
- CLDX -0.02
- Stochastic Oscillator
- AAT 80.39
- CLDX 60.32
About AAT American Assets Trust Inc.
American Assets Trust Inc is a self-administered real estate investment trust based in the United States. The company invests in, operates, and develops retail, office, residential, and mixed-use properties. Properties are predominantly located in South California, Northern California, Oregon, Washington, and Hawaii. American Assets operates through four segments based on property type: retail; office; mixed-use, which consists of retail and hotel components; and multifamily, which includes the company's apartment properties. The retail and office segments collectively contribute the majority of the total revenue.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.